http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101504410-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6f4e9b4f8739d4aaf5075512e9726eb
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
filingDate 2009-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36424f78e28d38fbc40b1f0f1513a332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4da02a82a3c97fcaa33dadd9fd71f542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcdca19e95fd9f292cff723f18c5d254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0de89183a870ffeaa122480cb141c70a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50c67c63e6bd2dc4e3fcbb3c198e20da
publicationDate 2009-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101504410-A
titleOfInvention Blood serum sample treatment preparation used for protein suspending chip detection
abstract The invention discloses a serum sample treating preparation used in a method for detecting a liquid phase protein by a suspension chip. The preparation comprises basic buffer solution, polyvinyl alcohol and polyvinylpyrrolidone, wherein the pH value of the basic buffer solution is between 5.5 and 9.0; the mass percentage of the polyvinyl alcohol in volume is between 0.05 and 1.5 percent; and the mass percentage of the polyvinylpyrrolidone in volume is between 0.05 and 2 percent. Because the serum sample treating preparation contains macromolecule surfactants of the polyvinyl alcohol and the polyvinylpyrrolidone, the preparation has the advantages of effectively lowering certain non-specific adsorption of the antibody, lowering background value and improving detection sensitivity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106596920-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110297085-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102175668-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109991408-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111089917-A
priorityDate 2009-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557696
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16684434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452490286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450984220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5102882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451936144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7618

Total number of triples: 35.